Vanguard Group Inc. Has $68.90 Million Position in Aehr Test Systems $AEHR

Vanguard Group Inc. lifted its stake in Aehr Test Systems (NASDAQ:AEHR) by 2.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,288,190 shares of the semiconductor company’s stock after buying an additional 65,444 shares during the period. Vanguard Group Inc. owned about 7.63% of Aehr Test Systems worth $68,897,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. State of Wyoming increased its stake in Aehr Test Systems by 26.7% during the third quarter. State of Wyoming now owns 2,777 shares of the semiconductor company’s stock valued at $84,000 after acquiring an additional 586 shares during the period. Jones Financial Companies Lllp lifted its position in shares of Aehr Test Systems by 3,448.3% in the 3rd quarter. Jones Financial Companies Lllp now owns 1,029 shares of the semiconductor company’s stock worth $31,000 after acquiring an additional 1,000 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Aehr Test Systems by 7.9% in the 2nd quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock worth $201,000 after acquiring an additional 1,145 shares during the period. CWM LLC grew its holdings in shares of Aehr Test Systems by 19.4% during the 3rd quarter. CWM LLC now owns 7,239 shares of the semiconductor company’s stock worth $218,000 after purchasing an additional 1,177 shares in the last quarter. Finally, Osaic Holdings Inc. grew its holdings in shares of Aehr Test Systems by 1.9% during the 2nd quarter. Osaic Holdings Inc. now owns 63,608 shares of the semiconductor company’s stock worth $822,000 after purchasing an additional 1,210 shares in the last quarter. 69.69% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

AEHR has been the subject of a number of recent research reports. Lake Street Capital started coverage on Aehr Test Systems in a research note on Wednesday, December 17th. They issued a “buy” rating for the company. Craig Hallum reissued a “hold” rating on shares of Aehr Test Systems in a report on Friday, January 9th. William Blair upgraded shares of Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research note on Monday, March 2nd. Weiss Ratings reiterated a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. Finally, Zacks Research raised shares of Aehr Test Systems from a “strong sell” rating to a “hold” rating in a research note on Monday, December 8th. Two research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Aehr Test Systems currently has a consensus rating of “Hold” and an average target price of $21.00.

Aehr Test Systems Price Performance

Aehr Test Systems stock opened at $35.61 on Friday. The business has a 50 day simple moving average of $29.17 and a 200 day simple moving average of $26.47. The company has a market capitalization of $1.09 billion, a PE ratio of -118.70 and a beta of 2.22. Aehr Test Systems has a one year low of $6.27 and a one year high of $46.95.

Aehr Test Systems (NASDAQ:AEHR) last announced its quarterly earnings results on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.04. Aehr Test Systems had a negative return on equity of 4.57% and a negative net margin of 16.63%.The firm had revenue of $9.88 million for the quarter, compared to analysts’ expectations of $11.45 million. Equities analysts anticipate that Aehr Test Systems will post 0.1 earnings per share for the current fiscal year.

Insider Buying and Selling at Aehr Test Systems

In other news, Director Rhea J. Posedel sold 13,998 shares of the company’s stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $30.02, for a total value of $420,219.96. Following the sale, the director owned 456,979 shares of the company’s stock, valued at approximately $13,718,509.58. This represents a 2.97% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Laura Oliphant sold 4,546 shares of the stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total transaction of $142,744.40. Following the sale, the director owned 18,432 shares of the company’s stock, valued at $578,764.80. This trade represents a 19.78% decrease in their position. The SEC filing for this sale provides additional information. 6.80% of the stock is currently owned by insiders.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.